Taniguchi T, Ko M, Seko S et al (2004) Interstitial pneumonia associated with autoimmune pancreatitis. Gut 53(5):770 (author reply 770–771)

CAS  PubMed  PubMed Central  Google Scholar 

Dispenzieri A, Fajgenbaum DC (2020) Overview of Castleman disease. Blood 135(16):1353–1364

Article  PubMed  Google Scholar 

Fajgenbaum DC, van Rhee F, Nabel CS (2014) HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood 123(19):2924–2933

Article  CAS  PubMed  Google Scholar 

Zhou J, Zhang L, Liu X et al (2023) Evolution of pulmonary involvement in idiopathic multicentric Castleman disease-not otherwise specified: from nodules to cysts or consolidation. Chest 164(2):418–428

Article  PubMed  Google Scholar 

Fajgenbaum DC, Uldrick TS, Bagg A et al (2017) International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 129(12):1646–1657

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishikori A, Nishimura MF, Nishimura Y et al (2022) Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric Castleman disease. Int J Mol Sci 23(18):10301

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang L, Dong YJ, Peng HL et al (2023) A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria. Lancet Reg Health West Pac 34:100720

PubMed  PubMed Central  Google Scholar 

Gao YH, Liu YT, Zhang MY et al (2024) Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: a distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. Br J Haematol 204(5):1830–1837

Article  PubMed  PubMed Central  Google Scholar 

Matsui S, Yamamoto H, Minamoto S et al (2016) Proposed diagnostic criteria for IgG4-related respiratory disease. Respir Investig 54(2):130–132

Article  PubMed  Google Scholar 

Wallace ZS, Naden RP, Chari S et al (2020) The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 79(1):77–87

Article  CAS  PubMed  Google Scholar 

van Rhee F, Voorhees P, Dispenzieri A et al (2018) International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 132(20):2115–2124

Article  PubMed  PubMed Central  Google Scholar 

Khosroshahi A, Wallace ZS, Crowe JL et al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67(7):1688–1699

Article  CAS  PubMed  Google Scholar 

Zhao EJ, Cheng CV, Mattman A et al (2021) Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management. Lancet Haematol 8(5):e365–e375

Article  CAS  PubMed  Google Scholar 

Terasaki Y, Ikushima S, Matsui S et al (2017) Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman’s disease. Histopathology 70(7):1114–1124

Article  PubMed  Google Scholar 

Otani K, Inoue D, Fujikura K et al (2018) Idiopathic multicentric Castleman’s disease: a clinicopathologic study in comparison with IgG4-related disease. Oncotarget 9(6):6691–6706

Article  PubMed  PubMed Central  Google Scholar 

Nishimura MF, Igawa T, Gion Y et al (2020) Pulmonary manifestations of plasma cell type idiopathic multicentric Castleman disease: a clinicopathological study in comparison with IgG4-related disease. J Pers Med 10(4):269

Article  PubMed  PubMed Central  Google Scholar 

Sasaki T, Akiyama M, Kaneko Y et al (2022) Immunoglobulin G4-related disease and idiopathic multicentric Castleman’s disease: confusable immune-mediated disorders. Rheumatology (Oxford) 61(2):490–501

Article  CAS  PubMed  Google Scholar 

Ogoshi T, Kido T, Yatera K et al (2013) Assessment of pathologically diagnosed patients with Castleman’s disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease. Lung 191(6):575–583

Article  CAS  PubMed  Google Scholar 

Zhang X, Zhang P, Peng L et al (2018) Clinical characteristics of a concurrent condition of IgG4-RD and Castleman’s disease. Clin Rheumatol 37(12):3387–3395

Article  PubMed  Google Scholar 

Kawano M, Hara S, Yachie A et al (2021) HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease. Rheumatology (Oxford) 60(1):e3–e4

Article  PubMed  Google Scholar 

Carruthers MN, Topazian MD, Khosroshahi A et al (2015) Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 74(6):1171–1177

Article  CAS  PubMed  Google Scholar 

Stone JH, Khosroshahi A, Zhang W et al (2024) Inebilizumab for treatment of IgG4-related disease. N Engl J Med. https://doi.org/10.1056/NEJMoa2409712

Article  PubMed  PubMed Central  Google Scholar 

Akiyama M, Yasuoka H, Yamaoka K et al (2016) Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Res Ther 18:167

Article  PubMed  PubMed Central  Google Scholar 

Della Torre E, Mattoo H, Mahajan VS et al (2014) Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 69(2):269–272

Article  CAS  PubMed  Google Scholar 

Sato Y, Kojima M, Takata K et al (2009) Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman’s disease. Mod Pathol 22(4):589–599

Article  CAS  PubMed  Google Scholar 

Sasaki T, Akiyama M, Kaneko Y et al (2017) Distinct features distinguishing IgG4-related disease from multicentric Castleman’s disease. RMD Open 3(1):e000432

Article  PubMed  PubMed Central  Google Scholar 

Kasashima S, Kawashima A, Zen Y et al (2018) Upregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients. J Vasc Surg 67(4):1248–1262

Article  PubMed  Google Scholar 

Akiyama M, Kaneko Y, Takeuchi T (2019) Characteristics and prognosis of IgG4-related periaortitis/periarteritis: a systematic literature review. Autoimmun Rev 18(9):102354

Article  CAS  PubMed  Google Scholar 

Yamamoto H, Sugiyama E, Serikawa M et al (2017) Clinical features and predictive value of serum inflammatory markers of perivascular involvement in immunoglobulin G4-related disease. Heart Vessels 32(10):1176–1185

Article  PubMed  Google Scholar 

Kasashima S, Kawashima A, Kasashima F et al (2018) Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessels 33(12):1471–1481

Article  PubMed  Google Scholar 

Liu AY, Nabel CS, Finkelman BS et al (2016) Idiopathic multicentric Castleman’s disease: a systematic literature review. Lancet Haematol 3(4):e163–e175

Article  PubMed  Google Scholar 

Chen LYC, Huang AJ, Stone JH et al (2024) Case 30-2024: a 45-year-old woman with kidney lesions and lytic bone disease. N Engl J Med 391(12):1140–1151

Article  PubMed  Google Scholar